$235 million announced for expansion of biotech sector at CSL By Dr Ananya Mandal, MD A $235 million growth of Australia’s largest biotech facility in Melbourne is planned and this is likely to create hundreds of jobs. CSL biopharmaceutical research complicated in Broadmeadows, in the north of Melbourne will become receiving this school funding from both State as well as Authorities over a five calendar year investment plan. This will create around 320 temporary construction jobs and 333 new highly-skilled medical research openings by 2018 later erectile dysfunction . Related StoriesSausages With Antioxidants From Berries To Prevent CancerMD Anderson research reveals why chemotherapy medicines not effective for many pancreatic cancer patientsNew results reveal association between colorectal malignancy and melanoma drug treatmentAt present CSL targets vaccine development but with the fresh funds more avenues of research like in cancer, blood related diseases, infections and inflammation as well as drug development and medical trials, are expected to open up.

Van Zwam, M.D., Ph.D., Yvo B.W.E.M. Roos, M.D., Ph.D., Aad van der Lugt, M.D., Ph.D., Robert J. Van Oostenbrugge, M.D., Ph.D., Charles B.L.M. Majoie, M.D., Ph.D., and Diederik W.J. Dippel, M.D., Ph.D. For the MR CLEAN Investigators: A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke.. Olvert A. Berkhemer, M.D., Puck S.S. Fransen, M.D., Debbie Beumer, M.D., Lucie A. Van den Berg, M.D., Hester F. Lingsma, Ph.D., Albert J. Yoo, M.D., Wouter J. Schonewille, M.D., Jan Albert Vos, M.D., Ph.D., Paul J. Nederkoorn, M.D., Ph.D., Marieke J.H. Wermer, M.D., Ph.D., Marianne A.A. Van Walderveen, M.D., Ph.D., Julie Staals, M.D., Ph.D., Jeannette Hofmeijer, M.D., Ph.D., Jacques A.